Back to Authors

Dickson, Euan J.

Mayo Clinic

University of Verona

Citations 2

The Influence of Intraoperative Blood Loss on Fistula Development Following Pancreatoduodenectomy
Trudeau, Maxwell T. , Casciani, Fabio , Seykora, Thomas F. , Asbun, Horacio J. , Ball, Chad G. , Bassi, Claudio , Behrman, Stephen W. , Berger, Adam C. , Bloomston, Mark P., Callery, Mark P., Castillo, Carlos Fernández‐del , Christein, John D. , Dillhoff, Mary , Dickson, Euan J., Dixon, Elijah , Fisher, William E., House, Michael G. , Malleo, Giuseppe , Salem, Ronald R. , Wolfgang, Christopher L. , Zureikat, Amer H., Vollmer, Charles M., Group, on behalf of the Pancreas Fistula Study, Maggino, Laura , Hughes, Steven J. , Kent, Tara Sotsky , Group, on behalf of the Pancreas Fistula Study

Annals of Surgery | November 17, 2020 | Volume: 276 | Issue: 5 | Pages: e527-e535

10.1097/sla.0000000000004549 Get It

Objective: To investigate the role of intraoperative estimated blood loss (EBL) on development of clinically relevant postoperative pancreatic fistula (CR-POPF) after pancreatoduodenectomy (PD). Background: Minimizing EBL has been shown to decrease transfusions and provide better perioperative outcomes in PD. EBL is also felt to be influential on CR-POPF development. Methods: This study consists of 5534 PDs from a 17-institution collaborative (2003–2018). EBL was progressively categorized (≤150mL; 151–400mL; 401–1,000 mL; > 1,000 mL). Impact of additive EBL was assessed using 20 3– factor fistula risk score (FRS) scenarios reflective of endogenous CR-POPF risk. Results: CR-POPF developed in 13.6% of patients (N = 753) and median EBL was 400 mL (interquartile range 250-600 mL). CR-POPF and Grade C POPF were associated with elevated EBL (median 350 vs 400 mL, P = 0.002; 372 vs 500 mL, P < 0.001, respectively). Progressive EBL cohorts displayed incremental CR-POPF rates (8.5%, 13.4%, 15.2%, 16.9%; P < 0.001). EBL >400mL was associated with increased CR-POPF occurrence in 13/20 endogenous risk scenarios. Moreover, 8 of 10 scenarios predicated on a soft gland demonstrated increased CR-POPF incidence. Hypothetical projections demonstrate significant reductions in CR-POPF can be obtained with 1–, 2–, and 3-point decreases in FRS points attributed to EBL risk (12.2%, 17.4%, and 20.0%; P < 0.001). This is especially pronounced in high-risk (FRS7–10) patients, who demonstrate up to a 31% reduction (P < 0.001). Surgeons in the lowest-quartile of median EBL demonstrated CR-POPF rates less than half those in the upper-quartile (7.9% vs 18.8%; P < 0.001). Conclusion: EBL independently contributes significant biological risk to CR-POPF. Substantial reductions in CR-POPF occurrence are projected and obtainable by minimizing EBL. Decreased individual surgeon EBL is associated with improvements in CR-POPF.
The Fistula Risk Score Catalog
Trudeau, Maxwell T. , Casciani, Fabio , Ecker, Brett L. , Seykora, Thomas F. , Puri, Priya , McMillan, Matthew T. , Miller, Benjamin C. , Pratt, Wande B., Asbun, Horacio J. , Ball, Chad G, Bassi, Claudio , Behrman, Stephen W. , Berger, Adam C. , Bloomston, Mark , Callery, Mark P., Castillo, Carlos Fernández‐del , Christein, John D. , Dillhoff, Mary , Dickson, Euan J., Dixon, Elijah , House, Michael G. , Hughes, Steven J. , Malleo, Giuseppe , Salem, Ronald R. , Wolfgang, Christopher L. , Vollmer, Charles M., Maggino, Laura , Ball, Chad G, Fisher, William P. , Kent, Tara Sotsky , Zureikat, Amer H.

Annals of Surgery | June 15, 2020 | Volume: 275 | Issue: 2 | Pages: e463-e472

10.1097/sla.0000000000004068 Get It

Objective: This study aims to present a full spectrum of individual patient presentations of pancreatic fistula risk, and to define the utility of mitigation strategies amongst some of the most prevalent, and vulnerable scenarios surgeons encounter. Background: The FRS has been utilized to identify technical strategies associated with reduced CR-POPF incidence across various risk strata. However, risk-stratification using the FRS has never been investigated with greater granularity. By deriving all possible combinations of FRS elements, individualized risk assessment could be utilized for precision medicine purposes. Methods: FRS profiles and outcomes of 5533 PDs were accrued from 17 international institutions (2003–2019). The FRS was used to derive 80 unique combinations of patient “scenarios.” Risk-matched analyses were conducted using a Bonferroni adjustment to identify scenarios with increased vulnerability for CR-POPF occurrence. Subsequently, these scenarios were analyzed using multivariable regression to explore optimal mitigation approaches. Results: The overall CR-POPF rate was 13.6%. All 80 possible scenarios were encountered, with the most frequent being scenario #1 (8.1%) – the only negligible-risk scenario (CR-POPF rate = 0.7%). The moderate-risk zone had the most scenarios (50), patients (N = 3246), CR-POPFs (65.2%), and greatest non-zero discrepancy in CR-POPF rates between scenarios (18-fold). In the risk-matched analysis, 2 scenarios (#59 and 60) displayed increased vulnerability for CR-POPF relative to the moderate-risk zone (both P < 0.001). Multivariable analysis revealed factors associated with CR-POPF in these scenarios: pancreaticogastrostomy reconstruction [odds ratio (OR) 4.67], omission of drain placement (OR 5.51), and prophylactic octreotide (OR 3.09). When comparing the utilization of best practice strategies to patients who did not have these conjointly utilized, there was a significant decrease in CR-POPF (10.7% vs 35.5%, P < 0.001; OR 0.20, 95% confidence interval 0.12–0.33). Conclusion: Through this data, a comprehensive fistula risk catalog has been created and the most clinically-impactful scenarios have been discerned. Focusing on individual scenarios provides a practical way to approach precision medicine, allowing for more directed and efficient management of CR-POPF.